Physician
Sebastian, Melinda
Sebastian, Melinda was paid $696K by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 50% of everything it billed.
33Billing provider infoSEBASTIAN, MELINDA
ALEXANDRIA, VA 22304
ALEXANDRIA, VA 22304
33aNPI1487755815assigned 09/26/2006
33bProvider typePediatrics Physician
28Total paid$696K
24GClaims22,664
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Virginia
Rank by total paid#132 of 817
Median peer was paid$29K
This provider vs. median24×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,812 | $138K | |
| 2019 | 4,483 | $118K | |
| 2020 | 2,867 | $89K | |
| 2021 | 2,933 | $93K | |
| 2022 | 3,053 | $97K | |
| 2023 | 2,819 | $98K | |
| 2024incomplete | 1,697 | $64K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 50% | 4,280 | 3,874 | $351K |
| 92553 | 9.8% | 2,165 | 2,122 | $69K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 9.2% | 1,150 | 1,082 | $64K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.7% | 533 | 524 | $40K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.4% | 453 | 448 | $37K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 3.8% | 3,239 | 3,096 | $26K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.7% | 249 | 247 | $19K |
| 86580 | 2.3% | 2,234 | 2,179 | $16K | |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 2.2% | 150 | 138 | $16K |
| 90688 | 1.8% | 1,114 | 1,079 | $13K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1.7% | 736 | 736 | $12K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.1% | 568 | 532 | $8K |
25 more codes
| 90651 | <1% | 123 | $5K | |
| 99173 | <1% | 2,211 | $5K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 26 | $2K |
| 99188 | <1% | 81 | $2K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 996 | $1K |
| 94760 | <1% | 862 | $1K | |
| 90619 | <1% | 12 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 40 | $1K |
| 90734 | <1% | 34 | $1K | |
| 90713 | <1% | 82 | $873.82 | |
| 90685 | <1% | 76 | $773.04 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 123 | $755.34 |
| 90700 | <1% | 54 | $604.50 | |
| 90670 | <1% | 13 | $533.72 | |
| 90461 | <1% | 180 | $341.90 | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 26 | $310.90 |
| 90633 | <1% | 27 | $253.00 | |
| A7016 | Dome and mouthpiece, used with small volume ultrasonic nebulizer | <1% | 51 | $251.13 |
| 90744 | <1% | 18 | $212.35 | |
| 90658 | <1% | 17 | $186.85 | |
| 90715 | <1% | 12 | $154.86 | |
| 99050 | <1% | 12 | $122.30 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 105 | $104.93 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 561 | $21.01 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 51 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.